Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Primary Care

Journal Scan / Research · November 23, 2024

Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease

The New England Journal of Medicine

 

Additional Info

Disclosure statements are available on the authors' profiles:

The New England Journal of Medicine
Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease
N. Engl. J. Med 2024 Oct 25;[EPub Ahead of Print], , WG Herrington, N Staplin, N Agrawal, C Wanner, JB Green, SJ Hauske, JR Emberson, D Preiss, P Judge, D Zhu, R Dayanandan, R Arimoto, KJ Mayne, SYA Ng, E Sammons, M Hill, W Stevens, K Wallendszus, S Brenner, AK Cheung, ZH Liu, J Li, LS Hooi, W Liu, T Kadowaki, M Nangaku, A Levin, DZI Cherney, AP Maggioni, R Pontremoli, R Deo, S Goto, X Rossello, KR Tuttle, D Steubl, D Massey, M Brueckmann, MJ Landray, C Baigent, R Haynes

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading